HT
SRNE

HAP Trading’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

HAP Trading’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-119,800
Closed -$2K – 1801
2022
Q4 		$2K Buy
119,800
+32,800
+38% +$43.5K ﹤0.01% 1384
2022
Q3 		$9K Sell
87,000
-7,800
-8% -$17.7K ﹤0.01% 1360
2022
Q2 		$20K Buy
94,800
+1,700
+2% +$2.94K ﹤0.01% 1332
2022
Q1 		$18K Buy
93,100
+39,200
+73% +$122K ﹤0.01% 1623
2021
Q4 		$13K Buy
53,900
+29,700
+123% +$184K ﹤0.01% 1979
2021
Q3 		$16K Sell
24,200
-3,100
-11% -$26.3K ﹤0.01% 1878
2021
Q2 		$44K Buy
27,300
+2,800
+11% +$22.3K ﹤0.01% 1523
2021
Q1 		$40K Sell
24,500
-45,800
-65% -$484K ﹤0.01% 1229
2020
Q4 		$139K Sell
70,300
-17,500
-20% -$141K ﹤0.01% 1061
2020
Q3 		$461K Sell
87,800
-111,900
-56% -$1.02M 0.02% 419
2020
Q2 		$536K Buy
+199,700
New +$765K 0.03% 420

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return

HAP Trading's SRNE Position: Q4 2021 in Review

HAP Trading sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2021, closing a stake of 61,523 shares — an estimated $382K sold.

HAP Trading first reported a position in SRNE in Q1 2021 and held it in 3 quarters. The position peaked at $469K in Q3 2021. 234 funds tracked by Wall St. Rank hold SRNE as of Q4 2021.

  • HAP Trading reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 61,523 Sorrento Therapeutics, Inc. shares in Q4 2021, an estimated $382K.
  • HAP Trading first reported a position in Sorrento Therapeutics, Inc. in Q1 2021 and held it in 3 quarters.
  • HAP Trading's Sorrento Therapeutics, Inc. position peaked at $469K in Q3 2021.
  • 234 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.